← Eichor
Condition: Tb Infection Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Tb Infection

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Dolutegravir Pharmacokinetics Among HIV/TB Coinfected Children Receiving Standard and High-dose Rifampicin
Phase 1 · 1 location(s) · Brigham and Women's Hospital · NCT05069688Evaluation of IGRA, Symptoms and Chest Radiograph for Subclinical TB Detection in ESRD and KT
Phase N/A · 1 location(s) · Mahidol University · NCT06700876Immunogenicity of COVID-19 Vaccines in Tuberculosis Patients
Phase N/A · 1 location(s) · University of Oxford · NCT05571735Integrating HIV Prevention With TB Household Contact Evaluation in Uganda
NA · 1 location(s) · University of Washington · NCT07119359ID93+GLA-SE Vaccine Against Tuberculosis in Older Adults Aged 55-74
Phase 1 · 4 location(s) · Quratis Inc. · NCT06714513Program for Rifampicin-Resistant Disease With Stratified Medicine for Tuberculosis
Phase 2/Phase 3 · 6 location(s) · University of California, San Francisco · NCT06441006Safety of Administering Isoniazid to SLE Patients to Prevent TB
Phase 2/Phase 3 · 1 location(s) · Universitas Padjadjaran · NCT06618573Tuberculosis in Rural and Malnourished Populations
NA · 1 location(s) · University of Virginia · NCT06971952Rapid Research in Diagnostics Development for TB Network
NA · 16 location(s) · University of California, San Francisco · NCT04923958Platform Assessing Regimens and Durations In a Global Multisite Consortium for TB
Phase 2 · 11 location(s) · University College, London · NCT06114628Novel Triple-dose Tuberculosis Retreatment Regimen
Phase 3 · 1 location(s) · Institute of Tropical Medicine, Belgium · NCT04260477ESAT6/CFP10 Skin Testing for TB Infection in Rheumatologic Patients
Phase N/A · 2 location(s) · Chinese University of Hong Kong · NCT06796647Innovating(IN) Shorter(S), All- Oral, Precised(P), Individualized(I) Treatment Regimen(RE) for Rifampicin Resistant Tube
Phase 3 · 5 location(s) · Huashan Hospital · NCT05081401Parent Study Name: Pulmonary Rehabilitation to Reduce Post-Tuberculosis Morbidity (TB Pure)
NA · 2 location(s) · Johns Hopkins University · NCT07164742Peer-led Implementation of TB-HIV Education and Adherence Counseling in Uganda
NA · 1 location(s) · Yale University · NCT05917210Pharmacokinetic Study to Evaluate Anti-mycobacterial Activity of TMC207 in Combination With Background Regimen (BR) of M
Phase 2 · 11 location(s) · Janssen Research & Development, LLC · NCT02354014Training Protocol on the Natural History of Tuberculosis
Phase N/A · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT01212003Asymptomatic TB With Innovative Modified Short-course Regimens
Phase 4 · 5 location(s) · Huashan Hospital · NCT06153069Respiratory Health and Wellbeing Post Pulmonary Tuberculosis
Phase N/A · 1 location(s) · Liverpool School of Tropical Medicine · NCT07178860Dolutegravir/Lamivudine Dual Therapy for ART-naïve People With HIV and TB Receiving Rifampin-based TB Treatment
Phase 3 · 6 location(s) · Johns Hopkins University · NCT06497465Sorfequiline-based Regimens in Adults With Newly Diagnosed Drug-sensitive Pulmonary TB
Phase 2 · 11 location(s) · Global Alliance for TB Drug Development · NCT07672405A Phase III Study of Oral Sudapyridine (WX-081) Tablets in Rifampicin-Resistant Pulmonary Tuberculosis Patients
Phase 3 · 2 location(s) · Shanghai Jiatan Pharmatech Co., Ltd · NCT05824871Testing Health Workers At Risk to Advance Our Understanding of TB Infection
Phase N/A · 1 location(s) · Beth Israel Deaconess Medical Center · NCT06221488ATORvastatin in Pulmonary TUBerculosis: a POPulation PharmacoKinetics -PharmacoDynamics Sub-study (ATORTUB popPK-PD)
Phase 2 · 3 location(s) · Obafemi Awolowo University Teaching Hospital · NCT07303699Bring BPaL2Me Trial Comparing Nurse-Led RR-TB Treatment to Physician-Led RR-TB Treatment
NA · 5 location(s) · Johns Hopkins University · NCT05671718A Study to Evaluate the Efficacy, Safety and Immunogenicity of MTBVAC in Adolescents and Adults Living in a TB Endemic R
Phase 2 · 16 location(s) · International AIDS Vaccine Initiative · NCT06272812Patients With Tuberculosis, Mycobacteriosis or Latent Tuberculosis
Phase N/A · 1 location(s) · IRCCS Azienda Ospedaliero-Universitaria di Bologna · NCT06764576Shortened Regimen for Drug-susceptible TB in Children
Phase 3 · 9 location(s) · Johns Hopkins University · NCT06253715A PAN-USR TB Multi-Center Trial
Phase 3 · 3 location(s) · Shenzhen Third People's Hospital · NCT06905522Rapid Research in Diagnostics Development for TB Network (R2D2 Kids) and Assessing Diagnostics At POC for TB in Children
NA · 3 location(s) · University of California, San Francisco · NCT05989802
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.